TIAN, Feng,GYMNOPOULOS, Marco,KNUDSEN, Nick,BECK, Andrew,SUN, Ying,BARNETT, Richard S.,PUTNAM, Anna-maria A. Hays
申请号：
AU2017200877
公开号：
AU2017200877B2
申请日:
2017.02.09
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2017200877B220180830.pdf#####ABSTRACT OF THE DISCLOSURE This invention relates to prostate-specific membrane antigen (PSMA) antibodies and antibody drug conjugates comprising at least one non-naturally-encoded amino acid. Disclosed herein are UPSMA 5 antibodies with one or more non-naturally encoded amino acids and further disclosed are antibody drug conjugates wherein the UPSMA antibodies of the invention are conjugated to one or more toxins. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, 10 dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid antibody drug conjugates, dolastatin analogs, and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology uses.
